Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease autosomal dominant polycystic kidney disease
Symptom C0020538|hypertension
Sentences 14
PubMedID- 20219618 hypertension in autosomal dominant polycystic kidney disease.
PubMedID- 24463189 Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.
PubMedID- 26254120 Pheochromocytoma as a rare cause of arterial hypertension in a patient with autosomal dominant polycystic kidney disease: a diagnostic and therapeutic dilemma.
PubMedID- 23971640 hypertension in children with autosomal dominant polycystic kidney disease (adpkd).
PubMedID- 23808746 hypertension is common in patients with autosomal dominant polycystic kidney disease (adpkd) very early usually already in adolescence and its occurrence precedes the decrease of glomerular filtration rate.
PubMedID- 21694639 Congenital hepatic fibrosis and portal hypertension in autosomal dominant polycystic kidney disease.
PubMedID- 25030010 Sympathetic overactivity plays a crucial role in the genesis and aggravation of arterial hypertension in patients with autosomal dominant polycystic kidney disease (adpkd).
PubMedID- 24621146 Renal sympathetic-nerve ablation for uncontrolled hypertension in a patient with single-kidney autosomal dominant polycystic kidney disease.
PubMedID- 25364490 hypertension in autosomal dominant polycystic kidney disease: a clinical and basic science perspective.
PubMedID- 23971639 Therapy of hypertension in autosomal dominant polycystic kidney disease with angiotensin-converting enzyme inhibitors or angiotensin receptor blocker has the potential to prevent cardiovascular complications and slow the progression of renal disease.
PubMedID- 25399731 Background: hypertension develops early in patients with autosomal dominant polycystic kidney disease (adpkd) and is associated with disease progression.
PubMedID- 25737691 Endothelial nitric oxide synthase gene expression is associated with hypertension in autosomal dominant polycystic kidney disease.
PubMedID- 20150584 Refractory ascites due to portal hypertension in autosomal dominant polycystic kidney disease (adpkd) patients successfully treated with peritoneal dialysis.
PubMedID- 22902029 Purpose: cyst proliferation in patients with autosomal dominant polycystic kidney disease is associated with renal failure, hypertension and pain.

Page: 1